Pathkey.ai Ltd Total Assets

Latest as of June 2025: AU$513.28K AUD ≈ $363.18K USD

Pathkey.ai Ltd total assets. Based on the latest financial reports, Pathkey.ai Ltd (PKY) holds total assets worth AU$513.28K AUD (≈ $363.18K USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Pathkey.ai Ltd stock valuation for the company's overall valuation and market capitalisation.

Total Assets of Pathkey.ai Ltd (1996–2025)

Total assets of Pathkey.ai Ltd from 1996 to 2025. This chart illustrates how Pathkey.ai Ltd's total assets have evolved over time, based on quarterly financial data. See Pathkey.ai Ltd share price for real-time trading data and today's change.

Pathkey.ai Ltd - Asset Composition Analysis

Pathkey.ai Ltd Total Assets Breakdown (June 2025)

Pathkey.ai Ltd total assets breakdown as of June 2025. Pathkey.ai Ltd's total assets of AU$513.28K consist of 97.1% current assets and 3.0% non-current assets.

Asset Category Amount (AUD) % of Total Assets
Cash & Equivalents AU$107.50K 0.0%
Accounts Receivable AU$56.77K 11.1%
Inventory AU$0.00 0.0%
Property, Plant & Equipment AU$15.16K 3.0%
Intangible Assets AU$0.00 0.0%
Goodwill AU$0.00 0.0%

Asset Composition Trend (1996–2025)

This chart illustrates how Pathkey.ai Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Pathkey.ai Ltd short-term liquidity ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Pathkey.ai Ltd's current assets represent 97.1% of total assets in 2025, an increase from 52.7% in 1996.
  • Cash Position: Cash and equivalents constituted 0.0% of total assets in 2025, down from 51.4% in 1996.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1996.
  • Asset Diversification: The largest asset category is cash and equivalents at 0.0% of total assets.

Pathkey.ai Ltd Competitors by Total Assets

Key competitors of Pathkey.ai Ltd based on total assets are shown below.

Company Country Total Assets
Longmaster Information Tech
SHE:300288
China CN¥1.30 Billion
Diagnos Inc
V:ADK
Canada CA$1.17 Million
Pro Medicus Ltd
AU:PME
Australia AU$610.14 Million
Cogstate Ltd
AU:CGS
Australia AU$64.77 Million
ARTRYA Ltd
AU:AYA
Australia AU$92.19 Million
Echoiq Ltd
AU:EIQ
Australia AU$17.99 Million
Alcidion Group Ltd
AU:ALC
Australia AU$115.63 Million
Resonance Health Ltd
AU:RHT
Australia AU$17.96 Million

Pathkey.ai Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.64 0.77 8.40
Quick Ratio 0.64 0.77 8.40
Cash Ratio 0.14 0.75 0.00
Working Capital AU$-283.53K AU$-114.00K AU$2.14 Million

Pathkey.ai Ltd - Advanced Valuation Insights

This section examines the relationship between Pathkey.ai Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio -
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) 24.7%
Total Assets AU$513.28K
Market Capitalization $106.54 USD

Valuation Analysis

Below Book Valuation: The market values Pathkey.ai Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Pathkey.ai Ltd's assets grew by 24.7% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Pathkey.ai Ltd (1996–2025)

The table below shows the annual total assets of Pathkey.ai Ltd from 1996 to 2025.

Year Total Assets Change
2025-06-30 AU$513.28K
≈ $363.18K
+24.70%
2024-06-30 AU$411.60K
≈ $291.23K
0.00%
2023-06-30 AU$411.60K
≈ $291.23K
-41.99%
2022-06-30 AU$709.58K
≈ $502.07K
-27.54%
2021-06-30 AU$979.22K
≈ $692.86K
-60.87%
2020-06-30 AU$2.50 Million
≈ $1.77 Million
+167.41%
2019-06-30 AU$935.77K
≈ $662.12K
+183.43%
2018-06-30 AU$330.15K
≈ $233.60K
-83.77%
2017-06-30 AU$2.03 Million
≈ $1.44 Million
+223.44%
2016-06-30 AU$628.78K
≈ $444.90K
-74.23%
2015-06-30 AU$2.44 Million
≈ $1.73 Million
-58.92%
2014-06-30 AU$5.94 Million
≈ $4.20 Million
-31.01%
2013-06-30 AU$8.61 Million
≈ $6.09 Million
-16.19%
2012-06-30 AU$10.27 Million
≈ $7.27 Million
-34.51%
2011-06-30 AU$15.69 Million
≈ $11.10 Million
+818.04%
2010-06-30 AU$1.71 Million
≈ $1.21 Million
+314.48%
2009-06-30 AU$412.32K
≈ $291.74K
-99.56%
2008-06-30 AU$93.76 Million
≈ $66.34 Million
+16.93%
2007-06-30 AU$80.19 Million
≈ $56.74 Million
+48.96%
2006-06-30 AU$53.83 Million
≈ $38.09 Million
+264.38%
2005-06-30 AU$14.77 Million
≈ $10.45 Million
-20.74%
2004-06-30 AU$18.64 Million
≈ $13.19 Million
+72.21%
2003-06-30 AU$10.82 Million
≈ $7.66 Million
+4.61%
2002-06-30 AU$10.35 Million
≈ $7.32 Million
+7.72%
2001-06-30 AU$9.61 Million
≈ $6.80 Million
-0.67%
2000-06-30 AU$9.67 Million
≈ $6.84 Million
+36.08%
1999-06-30 AU$7.11 Million
≈ $5.03 Million
+9.32%
1998-06-30 AU$6.50 Million
≈ $4.60 Million
+2.03%
1997-06-30 AU$6.37 Million
≈ $4.51 Million
-5.96%
1996-06-30 AU$6.77 Million
≈ $4.79 Million
--

About Pathkey.ai Ltd

AU:PKY Australia Health Information Services
Market Cap
$106.54
AU$150.58 AUD
Market Cap Rank
#32069 Global
#1845 in Australia
Share Price
AU$0.02
Change (1 day)
+0.00%
52-Week Range
AU$0.01 - AU$0.07
All Time High
AU$0.07
About

Pathkey.AI Ltd, a digital health company, involves artificial intelligence (AI) to improve clinical trials and predicting outcomes for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process. The com… Read more